ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Multivalent Rhamnose-Modified EGFR-Targeting Nanobody Gains Enhanced Innate Fc Effector Immunity and Overcomes Cetuximab Resistance via Recruitment of Endogenous Antibodies.

Yanchun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.